Patients
2.8 per 100,000 people
Suicide rate, Philippines, 2023 (WHO).
Compare every country on the Public Health Dashboard
Updated
Reviewed by Chandani Patel
Philippines Methamphetamine Use Public Health Report: Disease Burden, Demographic and Geographic Distribution, Risk Factors, Screening and Diagnosis, Treatment Coverage, Programmes, Gaps and Outlook
Only published figures are shown here, with their year and source. The full report keeps reported cases, survey estimates and modelled estimates apart, and names the data gaps.
| Topic | Methamphetamine Use |
|---|---|
| Place | Philippines |
| Suicide rate (latest) | 2.8 per 100,000 people (2023)Source: WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 19 Nov 2026. |
| Report sections | 16 (table of contents) |
| Formats | PDF, PPTX, XLSX |
Methamphetamine use is rising sharply in South-East Asia, causing psychosis, dependence and other harms. This report covers methamphetamine pills and crystal methamphetamine.
The report sets out the prevalence, incidence and, where relevant, deaths from methamphetamine use in the Philippines, and the overall burden, using Prevalence, Treatment Gap, Suicide Rate, Service Coverage and Mental Health Workforce.
The burden is broken down by age (children 5–14 years, adolescents 15–19 years, young adults 20–29 years, adults 30–59 years and adults 60 years and over), gender and income, with a focus on adolescents and young people, women in pregnancy and after birth, people affected by conflict, refugees and migrants, people who use drugs and people with chronic illness.
Findings are compared across states, provinces and districts where data allows, and between urban, rural and informal settlement areas, to show where needs are greatest and where gaps between places are widest.
Main risk factors include poverty and unemployment, violence and trauma, conflict and displacement, substance use, social isolation and stigma. Income, education, housing, water and sanitation, and gender and social norms are reviewed as social drivers of health.
The report reviews how aware people are of methamphetamine use and how far screening reaches them, through screening in primary care, school and community screening, validated screening tools and helplines, by group and by area.
It compares the number of people diagnosed with the estimated number affected, to show the undiagnosed burden and how many people are lost between screening and treatment.
Treatment and prevention covered include psychosocial treatment, community-based treatment, harm reduction and prevention in young people, with how many people receive treatment and how many stay on it.
Long-term effects covered include disability, suicide and self-harm, lost education and work and physical health problems, along with other conditions that often occur alongside methamphetamine use.
The report looks at primary care, community mental health services, psychiatric units in general hospitals and mental health workforce, the health workforce, and the physical, financial and distance barriers to care, including how people use public and private services.
PhilHealth is the national health insurer, and the Universal Health Care Act of 2019 makes every Filipino a member.[1] The Philippines scores 69 out of 100 on the WHO universal health coverage index (2023).[2] People pay 44.4% of all health spending out of their own pockets (2023).[3] Suicide rate: 2.8 per 100,000 people in 2023, the latest WHO figure for the Philippines.[4]
[1] PhilHealth. Checked 14 Nov 2026.
[2] WHO Global Health Observatory, Universal health coverage index (index (0–100)). Retrieved 19 Nov 2026.
[3] World Bank Open Data, Out-of-pocket spending (% of health spending). Retrieved 19 Nov 2026.
[4] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 20 Nov 2026.
It describes the costs of methamphetamine use to health systems and households, including out-of-pocket spending and lost productivity, and how government, donors and NGOs fund the response.
Worldwide guidance and funding for methamphetamine use include WHO Comprehensive Mental Health Action Plan 2013–2030, WHO Mental Health Gap Action Programme (mhGAP), WHO Special Initiative for Mental Health and IASC Guidelines on Mental Health and Psychosocial Support in Emergencies. The report reviews national programmes, donor and NGO funding, and what is known about their impact.
Year-wise trends and changes across survey rounds are shown and compared with peer countries, with the data collection year and reporting period stated for each figure.
The report names gaps in screening, diagnosis, treatment and access, the high-risk and underserved communities most affected, and where reliable data is missing.
It looks ahead at the likely future burden of methamphetamine use, the healthcare it will need and the areas most vulnerable.
The report closes with key findings, the population groups to prioritise and recommendations on where to target resources. Figures come from WHO Mental Health Atlas, Global Burden of Disease (IHME), National Mental Health Surveys and UNODC World Drug Report. Reported cases, survey estimates and modelled estimates are kept apart, and missing figures are named as data gaps.
What doctors and scientists are doing in Methamphetamine Use Public Health Report right now, from free public sources.
2.8 per 100,000 people
Suicide rate, Philippines, 2023 (WHO).
Compare every country on the Public Health DashboardSources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory, World Bank. Fetched 20 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] WHO Global Health Observatory, Suicide rate (per 100,000 people). Retrieved 19 Nov 2026.
[2] World Bank Open Data, Health spending per person (US$ per person). Retrieved 19 Nov 2026.
[3] World Bank Open Data, Doctors (per 1,000 people). Retrieved 19 Nov 2026.
From our blog
Philippines
Philippines
Philippines
Philippines
Philippines
Philippines
OTC & Nutraceuticals · Philippines
Pharmaceuticals · Philippines
Digital Health · Philippines
Digital Health · Philippines
Pharmaceuticals · Philippines
Pharmaceuticals · Philippines